These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 24014830

  • 1. MicroRNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation.
    Li P, Zhu N, Yi B, Wang N, Chen M, You X, Zhao X, Solomides CC, Qin Y, Sun J.
    Circ Res; 2013 Oct 25; 113(10):1117-27. PubMed ID: 24014830
    [Abstract] [Full Text] [Related]

  • 2. Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo.
    Iaconetti C, De Rosa S, Polimeni A, Sorrentino S, Gareri C, Carino A, Sabatino J, Colangelo M, Curcio A, Indolfi C.
    Cardiovasc Res; 2015 Sep 01; 107(4):522-33. PubMed ID: 25994172
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-124 controls human vascular smooth muscle cell phenotypic switch via Sp1.
    Tang Y, Yu S, Liu Y, Zhang J, Han L, Xu Z.
    Am J Physiol Heart Circ Physiol; 2017 Sep 01; 313(3):H641-H649. PubMed ID: 28667053
    [Abstract] [Full Text] [Related]

  • 4. Salvia miltiorrhiza-derived miRNAs suppress vascular remodeling through regulating OTUD7B/KLF4/NMHC IIA axis.
    Yang GS, Zheng B, Qin Y, Zhou J, Yang Z, Zhang XH, Zhao HY, Yang HJ, Wen JK.
    Theranostics; 2020 Sep 01; 10(17):7787-7811. PubMed ID: 32685020
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C.
    Circ Res; 2009 Jul 17; 105(2):158-66. PubMed ID: 19542014
    [Abstract] [Full Text] [Related]

  • 6. MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2.
    Feng S, Gao L, Zhang D, Tian X, Kong L, Shi H, Wu L, Huang Z, Du B, Liang C, Zhang Y, Yao R.
    Int J Biol Sci; 2019 Jul 17; 15(12):2615-2626. PubMed ID: 31754334
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-132 targeting PTEN contributes to cilostazol-promoted vascular smooth muscle cell differentiation.
    Chen WJ, Chen YH, Hsu YJ, Lin KH, Yeh YH.
    Atherosclerosis; 2018 Jul 17; 274():1-7. PubMed ID: 29738818
    [Abstract] [Full Text] [Related]

  • 8. miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation.
    Yang F, Chen Q, He S, Yang M, Maguire EM, An W, Afzal TA, Luong LA, Zhang L, Xiao Q.
    Circulation; 2018 Apr 24; 137(17):1824-1841. PubMed ID: 29246895
    [Abstract] [Full Text] [Related]

  • 9. The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.
    Choe N, Kwon JS, Kim JR, Eom GH, Kim Y, Nam KI, Ahn Y, Kee HJ, Kook H.
    Atherosclerosis; 2013 Aug 24; 229(2):348-55. PubMed ID: 23880186
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases.
    Farina FM, Hall IF, Serio S, Zani S, Climent M, Salvarani N, Carullo P, Civilini E, Condorelli G, Elia L, Quintavalle M.
    Circ Res; 2020 Jun 05; 126(12):e120-e135. PubMed ID: 32216529
    [Abstract] [Full Text] [Related]

  • 12. NCK Associated Protein 1 Modulated by miRNA-214 Determines Vascular Smooth Muscle Cell Migration, Proliferation, and Neointima Hyperplasia.
    Afzal TA, Luong LA, Chen D, Zhang C, Yang F, Chen Q, An W, Wilkes E, Yashiro K, Cutillas PR, Zhang L, Xiao Q.
    J Am Heart Assoc; 2016 Dec 07; 5(12):. PubMed ID: 27927633
    [Abstract] [Full Text] [Related]

  • 13. miRNA-34a reduces neointima formation through inhibiting smooth muscle cell proliferation and migration.
    Chen Q, Yang F, Guo M, Wen G, Zhang C, Luong le A, Zhu J, Xiao Q, Zhang L.
    J Mol Cell Cardiol; 2015 Dec 07; 89(Pt A):75-86. PubMed ID: 26493107
    [Abstract] [Full Text] [Related]

  • 14. Small nucleolar RNA host gene 18 controls vascular smooth muscle cell contractile phenotype and neointimal hyperplasia.
    Niu K, Zhang C, Yang M, Maguire EM, Shi Z, Sun S, Wu J, Liu C, An W, Wang X, Gao S, Ge S, Xiao Q.
    Cardiovasc Res; 2024 May 29; 120(7):796-810. PubMed ID: 38498586
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroRNA-15b/16 Attenuates Vascular Neointima Formation by Promoting the Contractile Phenotype of Vascular Smooth Muscle Through Targeting YAP.
    Xu F, Ahmed AS, Kang X, Hu G, Liu F, Zhang W, Zhou J.
    Arterioscler Thromb Vasc Biol; 2015 Oct 29; 35(10):2145-52. PubMed ID: 26293467
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-320 targeting neuropilin 1 inhibits proliferation and migration of vascular smooth muscle cells and neointimal formation.
    Li H, Zhao J, Liu B, Luo J, Li Z, Qin X, Wei Y.
    Int J Med Sci; 2019 Oct 29; 16(1):106-114. PubMed ID: 30662334
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes.
    Wang J, Yan CH, Li Y, Xu K, Tian XX, Peng CF, Tao J, Sun MY, Han YL.
    Exp Cell Res; 2013 May 01; 319(8):1165-75. PubMed ID: 23518389
    [Abstract] [Full Text] [Related]

  • 20. TNF-α elicits phenotypic and functional alterations of vascular smooth muscle cells by miR-155-5p-dependent down-regulation of cGMP-dependent kinase 1.
    Choi S, Park M, Kim J, Park W, Kim S, Lee DK, Hwang JY, Choe J, Won MH, Ryoo S, Ha KS, Kwon YG, Kim YM.
    J Biol Chem; 2018 Sep 21; 293(38):14812-14822. PubMed ID: 30104414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.